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The popular media and personal anecdotes are rich with examples of stress-induced eating
of calorically dense “comfort foods.” Such behavioral reactions likely contribute to the
increased prevalence of obesity in humans experiencing chronic stress or atypical
depression. However, the molecular substrates and neurocircuits controlling the complex
behaviors responsible for stress-based eating remain mostly unknown, and few animal
models have been described for probing the mechanisms orchestrating this response. Here,
we describe a system in which food-reward behavior, assessed using a conditioned place
preference (CPP) task, is monitored in mice after exposure to chronic social defeat stress
(CSDS), a model of prolonged psychosocial stress, featuring aspects of major depression
and posttraumatic stress disorder. Under this regime, CSDS increased both CPP for and
intake of high-fat diet, and stress-induced food-reward behavior was dependent on
signaling by the peptide hormone ghrelin. Also, signaling specifically in catecholaminergic
neurons mediated not only ghrelin’s orexigenic, antidepressant-like, and food-reward
behavioral effects, but also was sufficient to mediate stress-induced food-reward behavior.
Thus, this mouse model has allowed us to ascribe a role for ghrelin-engaged
catecholaminergic neurons in stress-induced eating.
Research Article
Find the latest version:
https://jci.me/57660/pdf
Research article
2684	 The	Journal	of	Clinical	Investigation	 	 	 http://www.jci.org	 	 	 Volume 121	 	 	 Number 7	 	 	 July 2011
Ghrelin mediates stress-induced  
food-reward behavior in mice
Jen-Chieh Chuang,1 Mario Perello,1 Ichiro Sakata,1 Sherri Osborne-Lawrence,1  
Joseph M. Savitt,2 Michael Lutter,1,3 and Jeffrey M. Zigman1,3,4
1Division of Hypothalamic Research, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.  
2Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 3Department of Psychiatry,  
The University of Texas Southwestern Medical Center, Dallas, Texas, USA. 4Divsion of Endocrinology and Metabolism,  















Most humans experience altered feeding behaviors upon stress, 
with approximately 40% eating more and 40% eating less than 
usual (1). Furthermore, upon stress, most people report an increase 
in the intake of highly palatable foods, independent of hyperpha-
gia or hypophagia (2, 3). Altered eating is also a frequent finding 
in individuals with major depressive disorder, with the “atypical” 
subtype even containing hyperphagia as a possible distinguish-
ing characteristic (4). In one study, 46% of study subjects who met 
DSM-IV criteria for major depressive disorder with atypical fea-
tures reported increased appetite (5). Of the remaining depressed 
patients without atypical features, 18% reported increased appe-
tite, while 50% reported decreased appetite (5). The complex eat-
ing behaviors that are associated with and/or stimulated by stress 
and major depression undoubtedly contribute to the increased 
number of overweight and obese individuals who experience or 
have experienced stress and depression. For example, a longitu-
dinal study from New Zealand showed that major depression in 
late-adolescent girls was associated with a 2.3-fold increased risk 
of obesity in adulthood and, furthermore, that the prevalence of 
obesity in adulthood was positively correlated with the number 
of major depressive episodes during adolescence in these girls (6). 
In another study, 47% of a large cohort of subjects with atypical 
depression reported increased body weight (5). Also, the combined 
overweight and obesity prevalence in a sample of US veterans with 
posttraumatic stress disorder was found in a chart review study to 
exceed that within the US general population by 20% (7).
Relatively few animal models have been developed to adequately 
explore the mechanisms responsible for complex, stress-induced 
and depression-associated eating behaviors. Animal models to 
investigate stress-based eating have included repeated bouts of 
restraint in rats, which was shown to increase intake of a freely 
available lard- and sucrose-based chow (8), and also a visible bur-
row system in rats, which led to increased meal size in subordinate 
males (9). A third model involved measuring intake of high-fat 
diet (HFD) pellets to which mice exposed to chronic variable stress 
were given limited access along with preweighed regular chow 
(10, 11). In this latter model, mice with genetic deletion of corti-
cotrophin-releasing factor receptor-2, which results in an exagger-
ated hypothalamic-pituitary-adrenal response to stress, showed an 
increase in HFD consumption during chronic variable stress (11). 
Furthermore, wild-type mice that previously had been calorically 
restricted and then were allowed to recover body weight consumed 
a significantly greater proportion of high-fat calories during 
chronic variable stress than did wild-type mice without previous 
calorie restriction (10). While these models have provided impor-
tant insights into stress-induced changes in feeding, no study has 
yet incorporated strategies to examine the more complex, motiva-
tion- and learning-associated decision-making processes likely at 
work in humans subjected to stress.
The lack of appropriate animal models, and, in particular (until 
recently; refs. 10, 11), mouse models, has also limited identifica-
tion of the actual molecular substrates involved in these stress-
induced eating behaviors. Thus, these substrates remain mostly 
undetermined. Emerging literature does suggest an association 
between stress and signaling by ghrelin, a peptide hormone pro-
duced primarily by distinct ghrelin cells located in the stomach 
and elsewhere in the gastrointestinal tract (12–15). Ghrelin’s roles 
in promoting food intake and positive energy balance in response 
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to caloric restriction have been documented in numerous studies 
(16–18). The mechanisms by which ghrelin promotes food intake 
are multifaceted and include enhancing the rewarding properties 
of certain foods (19–24). For instance, conditioned place prefer-
ence (CPP) for HFD, in which an animal will gravitate toward a 
chamber with environmental cues it has associated with a HFD 
reward, and operant nose poking for HFD, in which a motivated 
animal will exert increased effort (by poking a button with its nose) 
to receive a HFD reward, are induced in mice by peripheral ghrelin 
injection and prolonged caloric restriction, both of which increase 
plasma ghrelin (21, 23). Similarly, i.p. or i.c.v. ghrelin administra-
tion increases operant lever pressing for sucrose pellets in rats (24). 
Ghrelin receptor (growth hormone secretagogue receptor [GHSR]) 
antagonist administration and genetic deletion of GHSRs, though, 
prevents caloric restriction-associated CPP for HFD in mice (21, 
23). GHSR antagonist administration also prevents caloric restric-
tion-associated operant lever pressing for sucrose in rats (24). These 
findings suggest an obligatory role for ghrelin in caloric restriction-
associated food-reward behaviors. Supporting these findings, ghre-
lin injection preferentially enhances fat intake over carbohydrate 
intake in rats (22). Ghrelin administration increases consumption 
of palatable saccharin solution and increases preference for sac-
charin-flavored foods in wild-type mice but not GHSR-deficient 
mice (19). GHSR-deficient mice and GHSR antagonist-treated 
rats consume less peanut butter or Ensure but do not decrease 
consumption of regular chow in a free choice protocol (20). GHSR 
antagonist blocks CPP for chocolate pellets in satiated rats (20). 
Also, ghrelin administration to human subjects during functional 
magnetic resonance imaging increases the neural response to food 
pictures in brain regions implicated in hedonic feeding, confirming 
its importance in human appetite regulation (25).
Regarding a potential role for ghrelin in stress-based eating, ele-
vations of ghrelin have been observed in several animal and human 
stress models (26–31). For instance, human subjects subjected to 
the standardized trier social stress test display increased plasma 
ghrelin (30). The chronic social defeat stress (CSDS) procedure, 
which subjects male mice to repeated bouts of social subordina-
tion by an older and larger aggressor male, also leads to sustained 
plasma ghrelin elevations (26, 32, 33). After CSDS, most C57BL/6J 
male mice exhibit lasting depression-like behavioral deficits, includ-
ing social withdrawal (as measured using a social interaction task), 
which can be reversed by chronic, but not acute, antidepressant 
treatment (32). CSDS is thus considered a model of prolonged psy-
chosocial stress in humans, featuring aspects of major depression 
and posttraumatic stress disorder (32, 33). Of note, genetic deletion 
of GHSRs exacerbates depression-like behaviors normally induced 
by CSDS, while, conversely, pharmacologic and certain physi-
ologic (via chronic caloric restriction) ghrelin elevations produce 
antidepressant-like behavioral effects (26). Furthermore, CSDS is 
associated with hyperphagia by mice with access to freely available 
regular chow both during (26) and for at least 1 month after (26, 
34, 35) the defeat period. This hyperphagia, which is not observed 
in mice lacking GHSRs, may contribute to the higher body weight 
gain observed in CSDS-exposed C57BL/6J mice (26, 34, 35).
Here, we describe what we believe to be a new model, in which 
food-reward behavior, as assessed using a CPP task, is measured in 
mice after exposure to CSDS. We also have assessed the relation-
ship of stress-induced food-reward behavior to elevations in circu-
lating levels of the peptide hormone ghrelin, because of the afore-
mentioned studies demonstrating rises in ghrelin after various 
forms of stress, including CSDS (26, 31), and ghrelin-enhanced 
preference for, place preference for, and operant responding for 
pleasurable, energy-dense foods (19–22). We demonstrate that 
CSDS in mice increases both CPP for and intake of HFD. We also 
demonstrate that such stress-induced food-reward behavior is 
dependent on ghrelin signaling, as it is not observed in mice lack-
ing ghrelin receptors (GHSRs). Finally, we demonstrate that ghre-
lin signaling specifically in catecholaminergic neurons not only 
mediates certain of ghrelin’s orexigenic, antidepressant-like, and 
food-reward behavioral effects, but also is sufficient to mediate 
stress-induced food-reward behavior.
Results
Development of a mouse model of stress-induced complex eating behaviors 
and determination of the role of ghrelin in these behaviors. Based upon the 
observations that circulating ghrelin levels rise after various forms 
of stress, including CSDS (26, 31), and that ghrelin signaling 
increases the rewarding properties of energy-dense foods (19–22), 
we hypothesized that stress-induced elevations in ghrelin mediate 
reward behaviors aimed at obtaining calorically dense, pleasur-
able comfort foods upon social stress. To test this hypothesis, we 
developed what we believe to be a new mouse model to probe the 
molecular substrates and neurocircuits mediating stress-induced 
food-reward behavior. This model involved assessing CPP for HFD 
by mice after their exposure to CSDS.
We began by using both wild-type and ghrelin receptor-deficient 
(GHSR-null) littermates. As mentioned, CSDS results in several 
persisting behavioral deficits reminiscent of depression, includ-
ing social isolation (Figure 1, A and B, and refs. 32, 33). Consis-
tent with previous findings (26), CSDS-induced social isolation 
was intensified by genetic deletion of GHSRs (Figure 1, A and B). 
CSDS resulted in elevations of acyl-ghrelin (the confirmed ligand 
for GHSR), when assessed 1 day after the social interaction test 
(as had been reported previously; ref. 26), but not desacyl-ghrelin 
(Figure 1, C and D). Similar effects on ghrelin levels were observed 
in GHSR-null mice (Figure 1, C and D), suggesting that lack of 
ghrelin signaling does not impact plasma ghrelin in this physi-
ologic setting. Also, corticosterone levels measured 1 day after the 
social interaction test were higher in wild-type mice than in those 
in GHSR-null littermates after CSDS (Figure 1E). This seems rel-
evant to the differences in stress-associated, reward-based eating 
observed in wild-type versus GHSR-null littermates (described 
below), because glucocorticoid secretion intensifies motivated 
behaviors and increases intake of highly palatable foods (3).
One day after measurement of social interaction, CSDS- and 
non-CSDS-exposed mice were placed into a CPP for HFD protocol 
(21). After CSDS, wild-type mice demonstrated an increased pref-
erence for the chamber previously paired with HFD (Figure 2A), 
as had been previously demonstrated in wild-type mice exposed to 
other manipulations that raise ghrelin, including calorie restric-
tion and ghrelin administration (21). In contrast, neither CSDS-
exposed GHSR-null mice nor non-CSDS-exposed control subjects 
demonstrated CPP for HFD (Figure 2A).
Furthermore, CSDS-exposed wild-type mice gained more 
weight over the course of the CPP protocol than did control mice 
(as had been shown previously; refs. 34, 35) or GHSR-null mice 
(Figure 2B). Here, this observed increased body weight partly may 
be contributed to by a selective increased intake of HFD during 
the CPP conditioning sessions: the CSDS-exposed wild-type mice 
consumed more HFD during the conditioning sessions than did 
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the other groups (Figure 2C). Consistent with other experiments, 
demonstrating a selective effect of GHSR deletion on peanut but-
ter consumption but no effect on regular chow consumption in 
mice offered a free choice between those 2 diets (20), no differences 
were observed here in consumption of regular chow available dur-
ing the conditioning sessions (Figure 2D).
Importantly, previous control experiments (21), in which we 
assessed ghrelin’s pharmacological ability to induce CPP for HFD, 
determined that similar CPP results could be obtained upon rever-
sal of order of exposure to HFD and regular chow (in other words, 
conditioning with HFD on even days instead of on odd days) or 
upon use of quantities of HFD and regular chow that matched 
the mean amount of regular chow eaten during the condition-
ing sessions (instead of using equal calorie amounts of HFD and 
regular chow, as was done here). This suggests that it is the type of 
pellet rather than the order of pellet exposure or amount of food 
eaten during the conditioning sessions that determines the place 
preference in the task (21).
Determination of the role of ghrelin receptor-expressing catecholaminer-
gic neurons in ghrelin action. We next sought to determine neuronal 
subtypes and brain regions mediating ghrelin’s actions on stress-
induced food reward. GHSRs have a well-defined central expres-
sion pattern, which includes tyrosine hydroxylase–expressing (TH-
expressing) ventral tegmental area (VTA) neurons (36, 37). Extensive 
literature attributes essential roles to the VTA and its dopaminergic 
projections in mediating both reward behavior of various types and 
mood regulation, including that influenced by CSDS (38, 39). Sever-
al studies also have demonstrated that ghrelin can act on these VTA 
neurons to influence food intake and food reward (20, 36, 40–44).
Here, we assessed the role of direct action of ghrelin on VTA and 
other catecholaminergic neurons by generating mice in which 
GHSRs are expressed selectively at those sites. This was achieved 
by crossing GHSR-null mice, which contain a loxP-flanked tran-
scriptional blocking cassette inserted into the Ghsr gene, to mice in 
which Cre recombinase expression is driven by the TH promoter 
(TH-Cre mice) (45, 46). Study mice derived from this genetic cross, 
including wild-type mice (which contain GHSRs in all usual GHSR 
expression sites, with or without the TH-Cre transgene), GHSR-
null mice (which lack GHSRs), and GHSR-null/TH mice (which 
express endogenous levels of GHSRs only in TH-containing neu-
rons programmed to express both GHSR and TH), were previously 
used to demonstrate ghrelin-mediated protection against substan-
tia nigra cell loss and striatal dopamine loss after administration of 
the neurotoxin MPTP (47). Predicted patterns of TH cell–restricted 
GHSR expression within GHSR-null/TH mice were confirmed by 
real-time quantitative reverse transcription PCR (qRT-PCR) on 
tissue punches from different brain regions and by in situ hybrid-
ization histochemistry on coronal brain sections. In particular, 
within GHSR-null/TH mice, GHSR expression was observed in 
the VTA and arcuate nucleus (ARC) but not in sites known to lack 
TH-expressing neurons and/or GHSR-expressing neurons within 
wild-type mice, such as the dentate gyrus (DG), nucleus accumbens 
Figure 1
Intact acyl-ghrelin signaling via GHSRs minimizes CSDS-associated, depression-like behavior. CSDS induces depression-like behaviors, as 
indicated by (A) decreased time subjects spend in the interaction zone near the target mouse and (B) increased time subjects spend in the 
corners of the social interaction test arena, as compared with that of non-CSDS-exposed mice (n = 20 per group). GHSR deletion aggravates 
these behaviors (*P < 0.05, **P = 0.0012). (C) CSDS increases plasma acyl-ghrelin (D) but not desacyl-ghrelin, in wild-type and GHSR-null mice 
(n = 6–7 per group). (E) CSDS increases plasma corticosterone, but this effect is not as pronounced in GHSR-null mice (*P < 0.05; n = 15–18 
per group). Significant effects of treatment (CSDS vs. control non-CSDS) and significant genotype X treatment interactions are indicated.
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(NAC), or suprachiasmatic nucleus (SCN) (Figure 3A and Supple-
mental Figure 1; supplemental material available online with this 
article; doi:10.1172/JCI57660DS1). Of note, GHSR expression lev-
els within VTA and ARC tissue punches were not as high as those in 
the corresponding wild-type tissues, since GHSR expression within 
wild-type VTA and ARC also occurs in other, non-TH cell types (36, 
44, 48). Other sites of presumed usual GHSR-TH coexpression, in 
which TH-Cre–driven GHSR expression was observed by in situ 
hybridization histochemistry within GHSR-null/TH mice, included 
the substantia nigra, a few other hypothalamic sites (anteroventral 
periventricular nucleus, dorsomedial nucleus, and capsule of the 
ventromedial nucleus), and scattered caudal brainstem (nucleus of 
the solitary tract) cells, as reported previously (data not shown; ref. 
47). The TH-containing neurons in all of these sites are dopaminer-
gic, with the exception of the nucleus of the solitary tract TH-neu-
rons, which, based on studies in the rat, could be either adrenergic, 
noradrenergic, or dopaminergic (49).
As demonstrated previously (26, 45), wild-type mice, but not 
GHSR-null mice, responded to s.c. injections of ghrelin by increas-
ing their intake of freely available regular chow (Figure 3B). Reex-
pression of GHSR in TH-containing neurons partially restored 
ghrelin-induced food intake (Figure 3B). Similar to previous work 
(45, 50), fasting blood glucose levels were lower in GHSR-null mice 
than in wild-type littermates (Figure 3C). However, GHSR-null/
TH mice showed similar fasting blood glucose levels to those of 
GHSR-null mice, suggesting that direct action by ghrelin on cate-
cholaminergic neurons does not mediate its modulatory effects on 
glycemia (Figure 3C). Selective catecholaminergic GHSR expres-
sion also was shown to rescue ghrelin’s pharmacological ability to 
induce CPP for HFD (Figure 3D).
We next analyzed the effects of CSDS on social interaction and 
food intake by GHSR-null/TH mice. Consistent with previous 
findings, GHSR-null mice showed increased social isolation after 
CSDS compared with that of wild-type littermates (Figure 3E). 
Reexpression of GHSR in TH-containing neurons improved social 
interaction scores to levels similar to those observed in wild-type 
mice (Figure 3E), suggesting that catecholaminergic GHSR expres-
sion is sufficient to mediate ghrelin’s antidepressant actions. 
Finally, we assessed the performance of a separate cohort of mice 
in the CPP for HFD protocol after CSDS. Selective catecholamin-
ergic GHSR expression was sufficient to restore the chronic stress 
induction of CPP for HFD (Figure 3F).
Figure 2
CSDS enhances the rewarding properties of HFD, consumption of HFD reward pellets, and body weight gain in a ghrelin-dependent manner. 
(A) Unlike non-CSDS-exposed, control wild-type mice, CSDS-exposed wild-type mice demonstrate CPP for HFD (**P = 0.021). CSDS-induced 
HFD reward behavior is not observed in GHSR-null littermates (n = 20 per group). (B) CSDS-exposed wild-type mice gain more weight during the 
conditioning period than do the other groups (*P = 0.039) (n = 12 per group). (C) CSDS-exposed wild-type mice consume more HFD during CPP 
conditioning sessions than do non-CSDS-exposed control mice (***P = 0.006); such enhanced HFD intake is not observed in CSDS-exposed 
GHSR-null mice (n = 12 per group). (D) Consumption of the regular chow pellets available during CPP conditioning sessions is unaffected by 
CSDS in either genotype (n = 12 per group).
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Discussion
In summary, to our knowledge, the CSDS-induced CPP for HFD 
protocol described here is the first reported mouse model of an 
antidepressant-responsive, neuropsychiatric syndrome used to 
probe the mechanisms responsible for hedonic eating behaviors 
that occur upon chronic stress (32, 33). As mentioned, the CSDS 
protocol is considered a fairly representative model of prolonged 
psychosocial stress in humans and also produces a depression-like 
state, which, similar to major depressive disorder in humans, is 
known to be reversible only upon chronic, but not acute, admin-
istration of antidepressant agents (32, 33). Here, using a CPP pro-
tocol to examine complex, reward eating behaviors induced by 
the chronic stress/depression model, we were able to demonstrate 
stress-associated increases in both CPP for and intake of HFD. 
Thus, exposure of mice to CSDS prior to the CPP for HFD protocol 
models the complex changes in eating behavior and body weight 
gain associated with chronic stress and major depressive disor-
der — particularly the atypical subtype — in humans (1, 2, 5, 7). 
Figure 3
Selective GHSR expression in catecholaminergic neurons is sufficient for several ghrelin-mediated actions. (A) Cre-mediated restoration of Ghsr 
mRNA expression is observed in brain regions of GHSR-null/TH mice containing catecholaminergic neurons programmed to express GHSRs, 
including the ARC and VTA, as determined using qRT-PCR (n = 6 per group). Mean ± SEM threshold cycle values for Ghsr mRNA in each brain 
site are denoted above the bars. (B) Ghrelin-induced acute food intake is partially restored in GHSR-null/TH mice. (*P < 0.05, ***P < 0.0001) 
(C) Fasting blood glucose levels are not restored to wild-type levels in GHSR-null/TH mice (*P < 0.05). (D) Administered ghrelin-induced CPP 
for HFD (**P < 0.005, ***P < 0.0001), (E) social interaction phenotype after CSDS (*P < 0.05), and (F) CSDS-induced CPP for HFD (*P = 0.042, 
**P = 0.020) are all restored to wild-type levels in GHSR-null/TH mice. For B–F, n = 19–30 wild-type mice (including 12–22 mice without and 
5–14 mice with TH-cre), n = 14–34 GHSR-null mice, and n = 14–23 GHSR-null/TH mice. Significant effects of treatment (ghrelin vs. saline or ad 
libitum–fed versus 24-hour fast) and significant genotype X treatment interactions are indicated.
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Also, this model revealed a dependence of these food-reward 
behaviors on intact ghrelin signaling via GHSRs.
In addition, to our knowledge, this study contains the first 
major use of mice with conditionally manipulated ghrelin recep-
tor expression. More specifically, we showed that direct ghrelin 
signaling via GHSRs localized to catecholaminergic neurons was 
sufficient not only for CPP for HFD induced by ghrelin adminis-
tration and for usual mood responses after chronic stress but also 
for stress-induced food-reward behaviors.
A schematic model, which incorporates these findings with some 
previous results and which describes the proposed role of ghrelin 
and GHSR-TH–coexpressing neurons in stress-induced depression 
and eating behaviors, appears in Figure 4 and is further described 
as follows. We, and others, have shown that the CSDS protocol 
in mice, which is a model of prolonged psychosocial stress in 
humans, results in several persisting behavioral deficits reminis-
cent of depression (refs. 26, 32, 33, and Figure 4, part i). Psychoso-
cial stress also led to elevations in circulating levels of acyl-ghrelin, 
via a pathway which has not yet been elucidated (Figure 4, part ii). 
(Speculatively, this stress-induced elevation may involve stimula-
tion of β1-adrenergic receptors on ghrelin cells, as such a pathway 
has been shown to play a role in ghrelin release during a 24-hour 
fast and as increased sympathoadrenal tone is a known conse-
quence of stress [51–53]). Ghrelin, in turn, interacts with its recep-
tor, GHSR, which is found distributed throughout the brain and 
periphery in a specific pattern (37). The data in this report suggest 
that direct ghrelin interaction, specifically with GHSR-TH–coex-
pressing neurons (Figure 4, part iii), is sufficient for many of the 
behaviors induced in the setting of prolonged psychosocial stress. 
In particular, engagement of these catecholaminergic neurons by 
ghrelin minimized what would otherwise be worsened depres-
sion (as evidenced by the increased social avoidance in mice lack-
ing GHSRs after CSDS; Figure 4, part iv), while at the same time, 
induced various hedonic eating behaviors and hyperphagia (Fig-
ure 4, part v). Of note, direct ghrelin action on catecholaminergic 
neurons did not appear to mediate ghrelin’s effects on glycemia, as 
fasting blood glucose levels were similarly and significantly lower 
than wild-type levels in both GHSR-null and GHSR-null/TH mice. 
The effects on eating behavior led to increased intake of highly pal-
atable, calorically dense foods, which in the human experience are 
often termed comfort foods, and increased body weight (Figure 4, 
parti vi), which in turn can result in overweight and obesity.
Although the current study does focus in on the identity of 
those neurons that are sufficient for ghrelin’s actions in coordi-
nating the response to stress (GHSR neurons that coexpress TH 
or, rather, are catecholaminergic), the selectivity afforded by the 
TH-Cre mouse did not allow us to further narrow down the site 
of direct ghrelin action to one particular brain nucleus. None-
theless, we predict that GHSR-TH–coexpressing dopaminergic 
neurons in the VTA are very important in ghrelin’s actions in 
coordinating the response to stress. As mentioned, VTA dopami-
nergic neurons have long been known to play key roles in reward 
behavior of various types and mood regulation (38, 39), GHSRs 
are highly expressed in VTA dopaminergic neurons (36, 37), and 
ghrelin is known to act on these VTA neurons to influence food 
intake and food reward. For instance, ghrelin induces dopamine 
release in the NAC and increases action potential frequency in 
VTA dopamine neurons (36, 40, 41). Direct ghrelin microinjec-
tion into the VTA increases intake of freely available food, intake 
of a rewarding diet (peanut butter) over regular chow, and oper-
ant lever pressing for a sucrose reward (20, 36, 42, 43). Conversely, 
direct VTA microinjection of a GHSR antagonist decreases food 
intake in response to i.p. ghrelin and also decreases operant lever 
pressing for a sucrose reward normally induced by an overnight 
fast (36, 43). Also, rats containing VTA lesions consume less pea-
nut butter but equal regular chow amounts compared with that 
of sham-lesioned animals and spend less time exploring tubes 
containing peanut butter in response to i.c.v. ghrelin (20). Addi-
tionally, selective knockdown of GHSR expression in transgenic 
rats expressing an antisense GHSR transcript under the control 
of the TH promoter decreases food intake (44).
As mentioned, besides the VTA, there are other sites of pre-
sumed usual GHSR-TH coexpression, in which TH-Cre–driven 
GHSR expression was observed within GHSR-null/TH mice and 
in which ghrelin may act in the setting of stress on mood and/or 
eating. Most of these sites are dopaminergic, with the possible 
exception of scattered cells within the nucleus of the solitary 
tract (which, in the rat, have been shown to include neurons with 
adrenergic, noradrenergic, or dopaminergic signatures; ref. 49). 
Direct ghrelin action on GHSR-containing dopaminergic neu-
rons within the substantia nigra also could be mediating some 
of the complex food-reward behaviors we observed in the CSDS-
exposed mice, as neuronal projections from the substantia nigra 
to the dorsal striatum are involved in establishing efficient 
behavioral habits aimed at obtaining rewards (54). It would be 
even more speculative to propose a role for direct ghrelin action 
on dopaminergic (tuberoinfundibular) neurons within the ARC, 
since their known role has mainly been limited to regulatory 
effects on prolactin secretion (55).
Figure 4
Model of ghrelin’s roles in stress-induced behaviors. (i) CSDS in mice, 
which is a model of prolonged psychosocial stress in humans, results in 
several persisting behavioral deficits reminiscent of depression. (ii) Psy-
chosocial stress also leads to elevations in circulating levels of ghrelin, 
which, in turn (iii), interacts with GHSRs localized to catecholaminergic 
neurons in the brain (the exact expression site[s] of these GHSR-con-
taining, catecholaminergic neurons — most of which are dopaminergic 
— has not been identified but likely include the VTA). (iv) Engagement 
of these neurons by ghrelin induces a series of changes that minimizes 
what would otherwise be worsened depression-like behaviors, while at 
the same time, (v) induces HFD food-reward behavior and hyperpha-
gia, leading to (vi) increased intake of highly palatable, calorically dense 
comfort foods and increased body weight.
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It is also intriguing to speculate whether the mechanisms 
herein described for stress-associated food-reward behaviors may 
be generalized to other reward behaviors known to occur in the 
setting of psychosocial stress. An association between stress and 
an increased risk of abusing addictive substances already is well 
established (56–60). For example, chronic stress has been shown 
to be a strong predictor of addiction vulnerability (58), and post-
traumatic stress disorder is closely associated with an increased 
incidence of nicotine, alcohol, and other drug abuse (60). Exposure 
to stress has also been shown to reinstate drug-seeking behaviors 
in animal models and to increase chances of relapse in addictive 
individuals (61–63). Importantly, besides food-reward behaviors, 
ghrelin-signaling pathways also mediate alcohol-reward (64, 65), 
cocaine-reward (66–69), and nicotine-reward behaviors (70). Thus, 
ghrelin signaling, for instance, via catecholaminergic neurons, as 
described here, also may serve as an important link between chronic 
stress and drug reward.
We suspect that during evolution a link between stress, ghrelin, 
and eating behaviors may have instilled an important survival 
advantage. However, in today’s modern society, activation of these 
ghrelin-engaged catecholamine neurons instead may contribute 
substantively to the altered, complex eating behaviors and devel-
opment of overweight and obesity in humans exposed to chronic 
psychosocial stress and in humans with major depressive disorder. 
Future experiments should be aimed at determining the sufficiency 
and requirement specifically of the VTA in these actions of ghrelin 
as well as further clarifying the role for glucocorticoids in ghrelin 
action. Future studies also should focus on determining the signifi-
cance of GHSR expression in TH-containing neurons at other sites, 
for instance, the substantia nigra and the ARC. Furthermore, our 
described CSDS-CPP for HFD mouse model should prove extremely 
useful in future studies aimed at investigating the involvement of 
other hormones and neuronal signaling pathways in stress-induced 
eating of comfort foods and other stress-related, complex eating 
behaviors as well as future studies aimed at developing pharmaceu-
tical agents to curb these potentially detrimental behaviors.
Methods
Animal and housing. All procedures were performed in accordance with and 
with the approval of The University of Texas Southwestern Medical Cen-
ter Institutional Animal Care and Use Committee guidelines, using male 
mice which were housed in a 12-hour-light/dark cycle, with regular chow 
(2016 Teklad Global 16% Protein Rodent Diet, which provides 3.0 kcal/g 
[4.0 g% fat]) and water available ad libitum, unless otherwise stated. GHSR-
null mice, with their respective wild-type littermates, and GHSR-null/TH 
mice (with 2 GHSR-null alleles and 1 copy of TH-Cre), with their respec-
tive GHSR-null (with 2 GHSR-null alleles and no TH-Cre) and wild-type 
(with 2 wild-type GHSR alleles and 1 or no copies of TH-Cre) littermates, 
were generated as described previously (45, 46). All mice were on a pure 
C57BL/6J genetic background.
CSDS and social interaction task. CSDS is a 10-day protocol, based upon 
the resident-intruder paradigm, in which a test mouse is introduced into 
the home cage of a different aggressive CD1 mouse for a 5-minute physi-
cal encounter each day, followed by a sensory encounter for the remainder 
of each day, using a method reported recently (26). Control (non-CSDS-
exposed) mice received 5 minutes of gentle handling each day, instead of 
the physical exposure to an aggressive mouse experienced by the test mice, 
followed by a sensory encounter for the remainder of each day with a non-
aggressive C57BL/6J mouse. The social interaction task was used on day 
11 and involves placing mice in an arena with a small animal cage at one 
end, with their movement tracked for 2.5 minutes in the absence of another 
mouse, followed by 2.5 minutes in the presence of a caged, unfamiliar target 
CD1 mouse (26). Time spent in the interaction zone and in the corners of 
the arena was obtained using Ethovision 3.0 software (Noldus). CSDS and 
the social interaction task were performed using reported methods (26).
CPP. The general CPP for HFD protocol was performed as recently 
reported (21). Briefly, mice underwent a 12-day conditioning protocol, in 
which on odd days (days 1, 3, 5, 7, 9, and 11 of the CPP protocol) they were 
restricted for 20 minutes to one chamber of the CPP apparatus with HFD, 
and on even days (days 2, 4, 6, 8, 10, and 12 of the CPP protocol) they were 
restricted for 20 minutes to the other chamber of the CPP apparatus with 
an equal calorie amount (2.4 kcal) of regular chow. The regular chow pel-
lets are described above. The HFD pellets, which provide 5.56 kcal/g (35.8 
g% of fat and 58 kcal% fat), were from Research Diets (Rodent Chow prod-
uct no. D12331). The rest of the day was spent in their home cage with ad 
libitum access to regular chow. After the 12-day conditioning period, the 
mice were given free access for 30 minutes to the 2 chambers, each of which 
has a distinct wall pattern and floor texture, in the absence of either diet. 
Their CPP was determined by subtracting time spent in chamber paired 
with regular chow from time spent in chamber paired with HFD (test CPP 
score) and comparing the result to their preexisting place preference deter-
mined prior to conditioning (pretest CPP score). Importantly, 1 day prior 
to the pretest session, mice were exposed in their home cage to 1.0 g HFD 
to avoid neophobia during the task.
Here, CPP was performed by administering mouse acyl-ghrelin (Pi Pro-
teomics) (2 mg/kg body weight) s.c. 20 minutes before each conditioning 
session. Control animals instead received an equivalent volume of saline 
s.c. 20 minutes prior to each conditioning session. Alternatively, to assess 
CPP after CSDS, CSDS-exposed and control mice were placed in pretest, 
conditioning, and test sessions on days 13, 14–25, and 26, respectively, 
after the start of the 10-day CSDS procedure.
Blood glucose and hormone assessment. Blood glucose was measured at 9:00 
AM from tail blood of ad libitum–fed or 24-hour–fasted mice using a One-
Touch Ultra glucometer (LifeScan). Ghrelin levels were assessed at 11:00 
AM, 1 day after the social interaction task using tail blood processed by the 
addition of EDTA, PHMB, and HCl, as previously described (21). Corticos-
terone levels were assessed at 11:00 AM, 1 day after the social isolation task, 
using a distinct animal cohort, by ELISA (Assay Designs).
Brain punch sample collection and qRT-PCR analysis. Mice were euthanized 
by live decapitation. Brains were extracted, placed briefly in cold diethyl-
pyrocarbonate-PBS (DEPC-PBS), and then sectioned into 1-mm coronal 
slices by use of a stainless steel mouse brain matrix. The coronal slices 
were arranged in rostral-caudal order in DEPC-PBS, and small punches 
of tissue corresponding to the known locations of the ARC, VTA, DG, and 
NAC were excised using a 15-g needle. These brain regions were identi-
fied by comparing the coronal slices to a mouse brain atlas. Total RNA 
was isolated from these punches using RNA STAT-60 (Tel-Test Inc.). RNA 
concentrations were determined by absorbance at 260 nm with a Thermo 
Scientific Nanodrop 100 Spectrophotometer. The total RNA was treated 
with RNase-free DNase (Roche) and reverse-transcribed into cDNA with 
SuperScript II reagents (Invitrogen). Quantitative PCR was performed 
using an Applied Biosystems 7900HT Sequence Detection System and 
SYBR Green chemistry (Applied Biosystems). GHSR-specific primers were 
designed using Primer Express Software (PerkinElmer Life Sciences) and 
validated by analysis of template titration and dissociation curves. Primers 
mGHSR-QF1, 5′-ACCGTGATGGTATGGGTGTCG-3′, and mGHSR-QR1, 
5′-CACAGTGAGGCAGAAGACCG-3′, amplified a product within exon 2 
of the Ghsr gene. These results (which appear in Figure 3) were confirmed 
by a second set of mouse GHSR-specific primers, one of which is locat-
ed in exon 1 of the Ghsr gene (mGHSR-QF3 [5′-ATCTCCAGTGCCAG-
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GCACTGCT-3′]) and the other of which is located in exon 2 (mGHSR-GR3 
[5′-AATGGGCGCGAGCAGCAGGAA-3′]) of the Ghsr gene. The mRNA lev-
els are expressed relative to the housekeeping gene 36B4 and were calculat-
ed by the comparative threshold cycle (ΔΔCt) method (71), and the data are 
presented as a percentage of levels observed in wild-type ARC punches.
In situ hybridization histochemistry. To prepare tissues for histological exami-
nation, mice were deeply anesthetized with i.p. injection of chloral hydrate 
(500 mg/kg) and subsequently perfused transcardially with DEPC-treated 
0.9% PBS, followed by 10% neutral-buffered formalin. Brains were removed, 
stored in the same fixative for 4 to 6 hours at 4°C, immersed in 20% sucrose 
in DEPC-treated PBS, pH 7.0, at 4°C overnight, and cut on a freezing 
microtome coronally into 5 equal series at 25 μm. The sections were mounted 
on SuperFrost slides (Fisher Scientific), air dried, and stored at –20°C until 
further processing. In situ hybridization histochemistry for Ghsr mRNA was 
performed as reported previously (37) using a 33P-labeled mouse GHSR ribo-
probe generated from a 916-bp fragment of cDNA amplified with GHSR-
specific primers (mGHSR1047, 5′-GTGGTGTTTGCTTTCATCCTC-3′, 
and mGHSR1962, 5′-CATGCTCAAATTAAATGCATCC-3′). In situ hybrid-
ization histochemistry patterns were visualized first on autoradiographic 
film and then by observing slides dipped in photographic emulsion for 
direct, cellular visualization. Histological detail was noted by examining 
adjacent brain sections stained for thionin. Brain sections were viewed with 
both a Zeiss Axioskop and a Zeiss Stemi 2000-C dissecting microscope using 
both bright-field and dark-field optics. Photomicrographs were produced 
with a Zeiss digital camera attached to the microscopes and a Dell desk-
top computer. An image editing software program, Adobe PhotoShop 7.0, 
was used to combine the photomicrographs into plates, adjust contrast and 
brightness, and remove any obvious dust from the dark-field images. Pho-
tomicrographs taken from representative wild-type, GHSR-null, and GHSR-
null/TH mice at the levels of the midbrain, ARC, and SCN are included in 
Supplemental Figure 1 and demonstrate reexpression of Ghsr mRNA within 
a subset of VTA and ARC neurons from GHSR-null/TH mice. Reexpression 
in the VTA of GHSR-null/TH mice had also been shown previously using a 
different mouse GHSR-specific riboprobe (47). The mouse GHSR-specific 
riboprobe also detected TH-Cre–driven GHSR expression in the substantia 
nigra, a few other hypothalamic nuclei (anteroventral periventricular nucle-
us, dorsomedial nucleus, and capsule of the ventromedial nucleus), and the 
scattered nucleus of the solitary tract (caudal brainstem cells) from GHSR-
null/TH mice (data not shown).
Ghrelin-induced food intake. Mice were injected with saline or ghrelin 2 mg/kg 
body weight s.c. at 11:00 AM and intake of regular chow over the next 
2 hours was measured.
Statistics. Two-way ANOVA was performed when analyzing the effects of 
genotype and treatment on social interaction scores, plasma ghrelin and 
corticosterone levels, food intake and body weight changes during CPP, 
ghrelin-induced acute food intake, and blood glucose levels. Significant 
effects of treatment (CSDS vs. control non-CSDS, ghrelin vs. saline, or ad 
libitum–fed vs. 24-hour fast) and significant genotype X treatment inter-
actions are indicated in the appropriate figure panels. If significant geno-
type X treatment interactions were found, a secondary statistical analysis 
was performed using 1-way ANOVA. Statistical differences among groups 
resulting from this secondary analysis are indicated in the appropriate fig-
ure legends and panels. Alternatively, if no significant interaction between 
genotype and treatment was observed, statistical effects of one or both fac-
tors individually were determined using 2-tailed t tests, and statistically 
significant differences were denoted. Tukey-Kramer post-hoc analysis was 
used for all comparisons with significant P values.
One-way ANOVA was used to analyze the effect of genotype (wild-type vs. 
GHSR-null vs. GHSR-null/TH) on social interaction scores. The 2-tailed, 
paired t test was used to compare pretest versus test CPP scores within 
each CPP group.
Data are expressed as mean ± SEM. P < 0.05 was considered statistically 
significant, whereas P > 0.05 was considered not significant. Analyses were 
performed using GraphPad Prism 5.0.
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